As I understand, all hue and cry from Novartis is - they have invested big in R&D and yet not reaped reasonable returns. Also, they claim that this dents their effort to come with better drugs in future as profitability is at stack and such judgements are demotivating for any actual R&D to take place. Just wondering with crowdfunding gaining acceptance would this be a relevant argument ? What are real chances of getting a life saving drug as good as Imatinib seeing light of the day. What are practical challenges ?
As I understand, all hue and cry from Novartis is - they have invested big in R&D and yet not reaped reasonable returns. Also, they claim that this dents their effort to come with better drugs in future as profitability is at stack and such judgements are demotivating for any actual R&D to take place. Just wondering with crowdfunding gaining acceptance would this be a relevant argument ? What are real chances of getting a life saving drug as good as Imatinib seeing light of the day. What are practical challenges ?